CD44 contributes to T cell activation - PubMed (original) (raw)
. 1989 Aug 1;143(3):798-801.
Affiliations
- PMID: 2568380
CD44 contributes to T cell activation
S Huet et al. J Immunol. 1989.
Abstract
We demonstrate here that the CD44 molecule, which mediates lymphocyte adhesion to high endothelial venules (HEV), is also involved in the delivery of an activation signal to the T cell. We have produced a CD44 mAb (H90) which is able to block the binding of lymphocytes to high endothelial venules. H90 had no effect on [3H]TdR incorporation of whole PBL stimulated by lectins, allogeneic cells, or CD3 mAb in the soluble phase; in contrast, it strongly increased [3H]TdR incorporation of PBL stimulated by CD2 pairs of mAb or by CD3 mAb linked to the plastic culture plates, when purified T cells were used, H90 mAb could efficiently induce them to proliferate after a primary signal of activation delivered via cross-linked CD3 or via CD2, an effect mediated by Il-2 synthesis and Il-2R expression. Thus, the effect of H90 mAb resembles the mitogenic effect of CD28 "9.3" mAb. However, several results show that CD28 and CD44 mediate different signals to the T cells: i) in contrast to CD28 mAb, CD44 mAb cannot complement the signal delivered by a soluble CD3 mAb, lectins, or PMA; ii) CD44 mAb, at the difference of CD28 mAb, cannot induce CD3+ thymocytes to proliferate in conjunction with a first signal provided via cross-linked CD3 or via CD2; iii) F(ab) fragments of H90 were efficient, whereas divalent fragments of CD29 9.3 mAb are required to produce activation signals; and iv) CD44 and CD28 mAb produce a very strong synergistic effect on T cell proliferation. These results fit with previous ones showing that endothelial cells can play the role of accessory cell in T cell activation and that a hierarchy of signaling can be delivered to T cells via CD3 and CD2.
Similar articles
- CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA, Ledbetter JA, Lee K, June CH, Thompson CB. Turka LA, et al. J Immunol. 1990 Mar 1;144(5):1646-53. J Immunol. 1990. PMID: 2155264 - T cell activation via cell-surface antigens other than the CD3/T cell receptor complex.
Yokoyama WM, Shevach EM. Yokoyama WM, et al. Year Immunol. 1989;4:110-46. Year Immunol. 1989. PMID: 2467458 Review. No abstract available. - CD28 co-stimulation of T-cell-mediated cytotoxicity.
Azuma M, Phillips JH, Lanier LL. Azuma M, et al. Int J Cancer Suppl. 1992;7:33-5. Int J Cancer Suppl. 1992. PMID: 1330948 Review.
Cited by
- Mycobacterium tuberculosis produces D-serine under hypoxia to limit CD8+ T cell-dependent immunity in mice.
Cheng H, Ji Z, Wang Y, Li S, Tang T, Wang F, Peng C, Wu X, Cheng Y, Liu Z, Ma M, Wang J, Huang X, Wang L, Qin L, Liu H, Chen J, Zheng R, Feng CG, Cai X, Qu D, Ye L, Yang H, Ge B. Cheng H, et al. Nat Microbiol. 2024 Jul;9(7):1856-1872. doi: 10.1038/s41564-024-01701-1. Epub 2024 May 28. Nat Microbiol. 2024. PMID: 38806671 Free PMC article. - Spatial proteomics identifies a spectrum of immune dysregulation in acquired bone marrow failure syndromes.
Koldej RM, Prabahran A, Tan CW, Ludford-Menting M, Morgan H, Holzwart N, Davis MJ, Ritchie DS. Koldej RM, et al. Front Immunol. 2023 Sep 25;14:1213560. doi: 10.3389/fimmu.2023.1213560. eCollection 2023. Front Immunol. 2023. PMID: 37818364 Free PMC article. - Exploring the interaction between T-cell antigen receptor-related genes and MAPT or ACHE using integrated bioinformatics analysis.
Guo W, Gou X, Yu L, Zhang Q, Yang P, Pang M, Pang X, Pang C, Wei Y, Zhang X. Guo W, et al. Front Neurol. 2023 Mar 28;14:1129470. doi: 10.3389/fneur.2023.1129470. eCollection 2023. Front Neurol. 2023. PMID: 37056359 Free PMC article. - Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.
Uceda-Castro R, Margarido AS, Cornet L, Vegna S, Hahn K, Song JY, Putavet DA, van Geldorp M, Çitirikkaya CH, de Keizer PLJ, Ter Beek LC, Borst GR, Akkari L, van Tellingen O, Broekman MLD, Vennin C, van Rheenen J. Uceda-Castro R, et al. Cell Rep Med. 2022 Nov 15;3(11):100821. doi: 10.1016/j.xcrm.2022.100821. Cell Rep Med. 2022. PMID: 36384097 Free PMC article. - Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook.
Ruan Y, Chen L, Xie D, Luo T, Xu Y, Ye T, Chen X, Feng X, Wu X. Ruan Y, et al. Front Endocrinol (Lausanne). 2022 Apr 7;13:865436. doi: 10.3389/fendo.2022.865436. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35464064 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous